(Q74823150)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10147015%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

title

Recombinant granulocyte colony-stimulating factor (rG-CSF): pharmacoeconomic considerations in chemotherapy-induced neutropenia (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10147015%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

author name string

D Faulds

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10147015%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

N J Lewis

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10147015%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

R J Milne

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10147015%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

publication date

1 April 1992

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10147015%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10147015%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

volume

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10147015%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10147015%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

page(s)

231-249

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10147015%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.2165/00019053-199201040-00002

13 November 2019

exact match

0 references

cites work

Dose escalation study of recombinant human granulocyte-colony-stimulating factor (KRN8601) in patients with advanced malignancy

1 reference

12 December 2020

The use of granulocyte colony-stimulating factor to increase the intensity of treatment with doxorubicin in patients with advanced breast and ovarian cancer

1 reference

12 December 2020

Structural Characterization of Natural and Recombinant Human Granulocyte Colony-Stimulating Factors1

1 reference

12 December 2020

Current guidelines on the use of antibacterial drugs in patients with malignancies

1 reference

12 December 2020

Granulocyte colony-stimulating factor stimulates recovery of granulocytes in patients receiving dose-intensive chemotherapy without bone marrow transplantation

1 reference

12 December 2020

Recombinant human granulocyte colony-stimulating factor hastens granulocyte recovery after high-dose chemotherapy and autologous bone marrow transplantation in Hodgkin's disease

1 reference

12 December 2020

Disulfide and secondary structures of recombinant human granulocyte colony stimulating factor

1 reference

12 December 2020

Recombinant granulocyte colony-stimulating factor (rG-CSF). A review of its pharmacological properties and prospective role in neutropenic conditions

1 reference

12 December 2020

Cost comparison of seven antibiotic combinations as empiric therapy in a simulated febrile neutropenic patient

1 reference

12 December 2020

In vitro and in vivo analysis of the effects of recombinant human granulocyte colony-stimulating factor in patients

1 reference

12 December 2020

[A phase III study of KRN 8601 (rhG-CSF) on neutropenia induced by chemotherapy for malignant lymphoma--a multi-institutional placebo controlled double-blind comparative study]

1 reference

12 December 2020

Effect of granulocyte colony-stimulating factor on neutropenia due to chemotherapy for non-Hodgkin's lymphoma

1 reference

12 December 2020

Overview of empiric antibiotic therapy for the febrile neutropenic patient

1 reference

12 December 2020

Therapeutic granulocyte transfusions for documented infections. A controlled trial in ninety-five infectious granulocytopenic episodes

1 reference

12 December 2020

Phase I/II study of recombinant human granulocyte colony-stimulating factor in patients receiving intensive chemotherapy for small cell lung cancer

1 reference

12 December 2020

Beta-lactam antibiotic therapy in febrile granulocytopenic patients. A randomized trial comparing cefoperazone plus piperacillin, ceftazidime plus piperacillin, and imipenem alone

1 reference

12 December 2020

What is the cost of nephrotoxicity associated with aminoglycosides?

1 reference

12 December 2020

Pefloxacin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

1 reference

12 December 2020

Introduction and overview of hematopoietic growth factors

1 reference

12 December 2020

1 reference

12 December 2020

Granulocyte colony-stimulating factor and neutrophil recovery after high-dose chemotherapy and autologous bone marrow transplantation

1 reference

12 December 2020

Approaching the controversies in antibacterial management of cancer patients

1 reference

12 December 2020

Pharmacoeconomics of genetically engineered drugs

1 reference

12 December 2020

Effect of peripheral-blood progenitor cells mobilised by filgrastim (G-CSF) on platelet recovery after high-dose chemotherapy

1 reference

12 December 2020

Quantitative Relationships Between Circulating Leukocytes and Infection in Patients with Acute Leukemia

1 reference

12 December 2020

Ofloxacin. A reappraisal of its antimicrobial activity, pharmacology and therapeutic use.

1 reference

12 December 2020

Pharmacoeconomics of intravenous drug administration

1 reference

12 December 2020

The role of high-dose chemotherapy with autologous bone marrow transplantation in the treatment of breast cancer

1 reference

12 December 2020

Treatment of chemotherapy-induced neutropenia by subcutaneously administered granulocyte colony-stimulating factor with optimization of dose and duration of therapy

1 reference

12 December 2020

Advanced breast cancer: high-dose chemotherapy and bone marrow autotransplants

1 reference

12 December 2020

Ciprofloxacin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

1 reference

12 December 2020

Treatment of gram-positive septicemia in cancer patients

1 reference

12 December 2020

Symposium on infectious complications of neoplastic disease (Part I). Introduction and epidemiology.

1 reference

12 December 2020

Principles of pharmacoeconomic analysis of drug therapy

1 reference

12 December 2020

Teicoplanin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic potential

1 reference

12 December 2020

Hematopoietic growth factors

1 reference

12 December 2020

Reduction by Granulocyte Colony-Stimulating Factor of Fever and Neutropenia Induced by Chemotherapy in Patients with Small-Cell Lung Cancer

1 reference

12 December 2020

Neutropenia, fever, and infection

1 reference

12 December 2020

Outpatient use of ceftriaxone: a cost-benefit analysis

1 reference

12 December 2020

Effect of recombinant human granulocyte colony-stimulating factor (rG-CSF) on chemotherapy-induced neutropenia in patients with lung cancer

1 reference

12 December 2020

A randomized trial comparing ceftazidime alone with combination antibiotic therapy in cancer patients with fever and neutropenia

1 reference

12 December 2020

Effect of Granulocyte Colony-Stimulating Factor after Intensive Induction Therapy in Relapsed or Refractory Acute Leukemia

1 reference

12 December 2020

Effect of granulocyte colony-stimulating factor on neutropenia and associated morbidity due to chemotherapy for transitional-cell carcinoma of the urothelium

1 reference

12 December 2020

Effect of granulocyte colony stimulating factor on neutropenia induced by cytotoxic chemotherapy

1 reference

12 December 2020

Imipenem/cilastatin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic efficacy

1 reference

12 December 2020